G. Remuzzi

发表

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

Alan D. Lopez, Stephen S. Lim, H. R. Taylor, 2012, The Lancet.

Heterogeneous nature of renal lesions in type II diabetes.

G. Remuzzi, T. Bertani, G. Mecca, 1993, Journal of the American Society of Nephrology : JASN.

G. Remuzzi, M. Abbate, C. Zoja, 1989, Laboratory investigation; a journal of technical methods and pathology.

Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.

N. Perico, G. Remuzzi, M. Abbate, 1988, Laboratory investigation; a journal of technical methods and pathology.

Diets for patients with chronic kidney disease, still worth prescribing.

W. Mitch, G. Remuzzi, 2004, Journal of the American Society of Nephrology : JASN.

Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury.

G. Remuzzi, G. Remuzzi, 1995, Current opinion in nephrology and hypertension.

Renal biopsy in patients with acute renal failure and prolonged bleeding time: a preliminary report.

G. Remuzzi, G. Remuzzi, E. Gotti, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.

G. Remuzzi, T. Bertani, G. Mecca, 1982, Laboratory investigation; a journal of technical methods and pathology.

Nephrotoxicity of increased glomerular protein traffic.

A. Benigni, G. Remuzzi, M. Abbate, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.

N. Perico, G. Remuzzi, T. Bertani, 1994, Experimental nephrology.

Structural basis of diabetic nephropathy in microalbuminuric NIDDM patients: a light microscopy study

G. Remuzzi, T. Bertani, V. Gambara, 1996, Diabetologia.

Steroids and Adriamycin nephrosis.

G. Remuzzi, T. Bertani, M. Donati, 1984, Applied pathology.

Renal vascular and thrombotic effects of cyclosporine.

G. Remuzzi, G. Remuzzi, T. Bertani, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sequence of glomerular changes in experimental endotoxemia: a possible model of hemolytic uremic syndrome.

G. Remuzzi, M. Abbate, C. Zoja, 1989, Nephron.

Plasmapheresis in the treatment of acute renal failure in multiple myeloma.

G. Remuzzi, T. Bertani, G. Mecca, 1979, The American journal of medicine.

Renal injury induced by long-term administration of cyclosporin A to rats.

N. Perico, G. Remuzzi, M. Abbate, 1987, The American journal of pathology.

Pathophysiology of progressive nephropathies.

G. Remuzzi, G. Remuzzi, T. Bertani, 1998, The New England journal of medicine.

Superimposed nephritis: a separate entity among glomerular diseases?

G. Remuzzi, T. Bertani, G. Mecca, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Continuum of renoprotection with Losartan at all stages of type 2 diabetic nephropathy: A post hoc analysis of the RENAAL trial results: A post hoc analysis of the RENAAL trial results

B. Dimitrov, B. Brenner, G. Remuzzi, 2004 .

Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.

G. Remuzzi, P. Verroust, T. Bertani, 1983, Clinical and experimental immunology.

What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy?

S. Garattini, G. Remuzzi, T. Bertani, 1987, Nephron.

The Glomerulus: Mechanisms of Injury

B. Bikbov, N. Perico, G. Remuzzi, 2010 .

Adriamycin-induced glomerulosclerosis in the rat.

G. Remuzzi, T. Bertani, G. Mecca, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

G. Remuzzi, T. Bertani, 1990, Kidney international.

Steroids and cytotoxic drugs in the treatment of membranous glomerulopathy.

S. Garattini, G. Remuzzi, T. Bertani, 1988, Nephron.

The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

M. Schluchter, B. Brenner, J. McGill, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Haemolytic uraemic syndrome: therapeutic effect of plasma infusion.

A. Edefonti, G. Remuzzi, G. Remuzzi, 1982, British medical journal.

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

C. Schmid, A. Levey, G. Remuzzi, 2001, Kidney international.

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

Alan D. Lopez, Stephen S. Lim, H. R. Taylor, 2012, The Lancet.